According to a new laboratory study, it has been revealed that pomegranate, which is an effective fruit for convalescence patients, can now also be used for the treatment of some lethal diseases like women breast cancer, largely estrogen responsive ones. The pomegranate fruit is rich in antioxidants and the chemicals in it could prevent estrogen responsive breast cancer in women.
Breast cancer has become a prevalent disease and categorized into chronic disabling diseases among others like heart attack, arthritis etc. It has been diseases among others like heart attack, arthritis etc. It has been reported that more than 400,000 women dies every year around the world from this disease.
Around 75% of breast cancer is estrogen related and researchers are continually striving for some better methods to curb this lethal disease. In a recent study conducted by Ohio State University, researchers focused on the curing of breast cancer from the pomegranate juice. The fruit oozes a chemical known as ellagic acid that seems to slow down the cancerous cells in breast tissues, even in some cases completely cure the tissue.
According to researchers, the fruit contains high level of antioxidants and potential cancer fighting attributes. It is not only in fighting cancer but also help to keep the heart healthy. An enzyme aromatase, which plays a key role to aggravate estrogen production and thus, promote the cancerous tissue in breast.
The team of researchers conducted test of ten ellagitannin derived compounds produced by the pomegranates, which are supposed to have potential capacity to prevent estrogen related breast cancer. They considered the effects of the ten compounds on the growth of breast cancer cells and aromatase activity. Out of these ten derivatives, urolithin B was the master chemical that prevent the cancer tissues to ramify.
While doctors still to recommend pomegranate as a substitute for prescribed medicine, but it is well calculated anticipation that in future the fruit will being used for breast cancer. Many stalwarts in this field hope to gain a positive result from the study.
Breast cancer has become a prevalent disease and categorized into chronic disabling diseases among others like heart attack, arthritis etc. It has been diseases among others like heart attack, arthritis etc. It has been reported that more than 400,000 women dies every year around the world from this disease.
Around 75% of breast cancer is estrogen related and researchers are continually striving for some better methods to curb this lethal disease. In a recent study conducted by Ohio State University, researchers focused on the curing of breast cancer from the pomegranate juice. The fruit oozes a chemical known as ellagic acid that seems to slow down the cancerous cells in breast tissues, even in some cases completely cure the tissue.
According to researchers, the fruit contains high level of antioxidants and potential cancer fighting attributes. It is not only in fighting cancer but also help to keep the heart healthy. An enzyme aromatase, which plays a key role to aggravate estrogen production and thus, promote the cancerous tissue in breast.
The team of researchers conducted test of ten ellagitannin derived compounds produced by the pomegranates, which are supposed to have potential capacity to prevent estrogen related breast cancer. They considered the effects of the ten compounds on the growth of breast cancer cells and aromatase activity. Out of these ten derivatives, urolithin B was the master chemical that prevent the cancer tissues to ramify.
While doctors still to recommend pomegranate as a substitute for prescribed medicine, but it is well calculated anticipation that in future the fruit will being used for breast cancer. Many stalwarts in this field hope to gain a positive result from the study.
0 comments: